Vonoprazan and amoxicillin dual therapy as the first‐line treatment of <i>Helicobacter pylori</i> infection: A systematic review and meta‐analysis
2023 · Helicobacter · 36 citations
https://doi.org/10.1111/hel.13039
R
Ren‐Chun Du
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
100
Citations
3
h-index
2
i10-index
Ren‐Chun Du is an academic researcher from Nanchang University. The author has contributed to research in topics: Helicobacter pylori-related gastroenterology studies & Gastroesophageal reflux and treatments & Gastric Cancer Management and Outcomes. The author has an h-index of 3, co-authored 5 publications.
Papers by this author
worksAssessing the Capabilities of Novel Open‐Source Artificial Intelligence—<scp>DeepSeek</scp> in <scp><i>Helicobacter pylori</i></scp>‐Related Queries
2025 · Helicobacter · 2 citations
https://doi.org/10.1111/hel.70045
40 years after the discovery of <i>Helicobacter Pylori</i>: Performing optimized “subtraction” for clinical eradication
2025 · iMetaOmics. · 1 citations
https://doi.org/10.1002/imo2.70017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat